DD210059A5 - Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt - Google Patents

Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt Download PDF

Info

Publication number
DD210059A5
DD210059A5 DD83253195A DD25319583A DD210059A5 DD 210059 A5 DD210059 A5 DD 210059A5 DD 83253195 A DD83253195 A DD 83253195A DD 25319583 A DD25319583 A DD 25319583A DD 210059 A5 DD210059 A5 DD 210059A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
optionally substituted
compound
hydrogen
alkanoyl
Prior art date
Application number
DD83253195A
Other languages
German (de)
English (en)
Inventor
Herbert A Kirst
John E Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD210059A5 publication Critical patent/DD210059A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Steroid Compounds (AREA)
DD83253195A 1982-07-19 1983-07-19 Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt DD210059A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/399,656 US4452784A (en) 1982-07-19 1982-07-19 C-23-Modified derivatives of DMT

Publications (1)

Publication Number Publication Date
DD210059A5 true DD210059A5 (de) 1984-05-30

Family

ID=23580425

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83253195A DD210059A5 (de) 1982-07-19 1983-07-19 Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt

Country Status (19)

Country Link
US (1) US4452784A (fr)
EP (1) EP0099746B1 (fr)
JP (1) JPS5931796A (fr)
KR (1) KR850000966B1 (fr)
AT (1) ATE23047T1 (fr)
AU (1) AU1693583A (fr)
CA (1) CA1202964A (fr)
DD (1) DD210059A5 (fr)
DE (1) DE3367104D1 (fr)
DK (1) DK330483D0 (fr)
ES (1) ES8504841A1 (fr)
FI (1) FI832604A7 (fr)
GB (1) GB2123827B (fr)
GR (1) GR78387B (fr)
NZ (1) NZ204940A (fr)
PH (1) PH19727A (fr)
PL (1) PL243091A1 (fr)
PT (1) PT77040A (fr)
ZA (1) ZA835216B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
US4656258A (en) * 1983-03-03 1987-04-07 Eli Lilly And Company Macrocin derivatives
JPS62103098A (ja) * 1985-05-13 1987-05-13 Microbial Chem Res Found タイロシン誘導体
PT87417B (pt) * 1987-05-06 1992-08-31 Adir Processo para a preparacao de novos compostos macrolidos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667952A (fr) * 1964-08-05
US4358584A (en) * 1979-05-23 1982-11-09 Eli Lilly And Company Antibiotics A6888C and A6888X
JPS56122397A (en) * 1980-02-29 1981-09-25 Satoshi Omura Marcolides
US4321361A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company Demycinosyltylosin and process for its production
ZA813578B (en) * 1980-06-12 1983-01-26 Lilly Co Eli Macrolide antibiotics
US4438109A (en) * 1980-07-25 1984-03-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Tylosin derivatives
US4304856A (en) * 1980-11-10 1981-12-08 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin
US4341771A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling Pasteurella infections
US4341770A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling ureaplasma infections
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use

Also Published As

Publication number Publication date
ES524197A0 (es) 1985-05-01
KR840005462A (ko) 1984-11-12
ES8504841A1 (es) 1985-05-01
EP0099746B1 (fr) 1986-10-22
GB8319306D0 (en) 1983-08-17
AU1693583A (en) 1984-01-26
GB2123827A (en) 1984-02-08
GB2123827B (en) 1986-07-30
NZ204940A (en) 1985-11-08
US4452784A (en) 1984-06-05
DK330483D0 (da) 1983-07-18
PH19727A (en) 1986-06-17
GR78387B (fr) 1984-09-26
ZA835216B (en) 1984-03-28
FI832604A7 (fi) 1984-01-20
ATE23047T1 (de) 1986-11-15
JPS5931796A (ja) 1984-02-20
DE3367104D1 (en) 1986-11-27
FI832604A0 (fi) 1983-07-18
KR850000966B1 (ko) 1985-07-02
PL243091A1 (en) 1984-07-16
PT77040A (en) 1983-08-01
EP0099746A1 (fr) 1984-02-01
CA1202964A (fr) 1986-04-08

Similar Documents

Publication Publication Date Title
DE69733422T2 (de) 6-0-substituierte ketoliden mit antibakteriellen wirkung
DE69409360T2 (de) Neue antiparasitische mittel, derivate von milbemycin und avermectin
CH648037A5 (de) Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
CH655728A5 (de) Erythromycin a-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung.
DE2819479C2 (fr)
DD210284A5 (de) Verfahren zur herstellung von 20-aminomakrolidderivaten
DE69814441T2 (de) 6,11-verbrückte erythromycinderivate
DD210283A5 (de) Verfahren zur herstellung von 20-aminotylosin-derivaten
DE2804508C2 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung als antibakterielle Wirkstoffe
DE2462691C2 (fr)
DE2937267C2 (fr)
DE2900118C2 (fr)
DE2537375C3 (de) 93",4"-Triacylester des Antibioticums SF-837 M, und Verfahren zur Herstellung derselben sowie Arzneimittel mit einem Gehalt an diesen Verbindungen
DE2804517C3 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung bei der Bekämpfung von Bakterien
DE3878835T2 (de) Antibakterielle 9-deoxy-9a-allyl und propargyl-9a-aza-9a-homoerythromycin-a-derivate.
DD210060A5 (de) Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten
DE2733867B2 (de) Oleandomycinderivate und diese Verbindungen enthaltende antibakterielle Mittel
DE3788389T2 (de) Cervinomycinabkömmlinge als antibiotika und deren herstellungsverfahren.
US4452784A (en) C-23-Modified derivatives of DMT
DE60005334T2 (de) 6-o-carbamat ketolide derivate
DE3308196C2 (fr)
DE2804507C2 (de) 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel
DE2754323C2 (fr)
DE60115851T2 (de) Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
AT371481B (de) Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von erythromycin